Medical News

RSS

Inhalation of nitric oxide could help improve blood flow to ischemic brain

LMU researchers developed a new strategy for the treatment of stroke, which could help to improve blood flow to ischemic brain. Strokes are due to a localized reduction in the blood supply to the brain, mainly due to the blockage of a vessel by a blood clot.

5 Mar 2012

Health care a big budget issue for Minn., Va. lawmakers

Lower health spending because of slower Medicaid enrollment growth is good news for Minnesota's budget. In Virginia, however, Democrats say a GOP budget doesn't spend enough on health care.

5 Mar 2012

Innovative telemedicine program connects neonatal specialists to treat tiniest, difficult cases

An innovative telemedicine program connecting neonatal specialists from UC San Diego Medical Center and Tri-City Medical Center's Neonatal Intensive Care Unit (NICU) will allow experts to collaborate, diagnose and treat some of San Diego County's tiniest, most difficult cases.

5 Mar 2012

Interaction sends letter to CIA head protesting use of vaccination plot to find Bin Laden in Pakistan

"An alliance of 200 U.S. aid groups has written to the head of the CIA to protest against its use of a doctor to help track Osama bin Laden, linking the agency's ploy to the polio crisis in Pakistan," the Guardian reports, noting Pakistan recorded the highest number of polio cases in the world last year.

5 Mar 2012

Cell-based test to discover molecules to treat ER-positive breast cancer

Cancer Research UK and its commercial arm, Cancer Research Technology have developed a unique test to discover molecules that could lead to potential new treatments for oestrogen receptor (ER)-positive breast cancer.

5 Mar 2012

USAID committed to early action on Sahel drought, drawing from lessons from Horn response

"A year after the worst drought in 60 years sent 13.3 million people in the Horn of Africa into crisis, we are now facing a rising threat of crisis in the Sahel -- an arid belt that stretches from Senegal through Niger and Burkina Faso to Chad," Nancy Lindborg, head of democracy, conflict, and humanitarian assistance at USAID, writes in this post in Huffington Post's "The Blog."

5 Mar 2012

Thrombotech receives FDA IND approval for THR-18 Phase IIa clinical trial in stroke victims

Hadasit Bio-Holdings a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced Thrombotech Ltd., a portfolio company which Hadasit holds a 24% stake in, received an IND approval from the Food and Drug Administration enabling the initiation of a Phase IIa clinical trial in the U.S.

5 Mar 2012

IRIN examines pilot project to increase ORS coverage for treatment of child diarrhea

IRIN examines ColaLife -- a pilot project set to start in Zambia in September 2012 that will ship single-dose anti-diarrhea kits (ADKs) in crates of Coca-Cola bottles in an effort to increase the coverage of oral rehydration salts (ORS) for the treatment of diarrhea in children in the developing world.

5 Mar 2012

FDA clears UELS contactless breast cancer imaging tool

UE LifeSciences Inc. (UELS), a medical device manufacturer focused on providing novel breast cancer screening solutions, announced today that it has received market clearance from the U.S. Food and Drug Administration (FDA) for its NoTouch BreastScan™ device. NoTouch BreastScan™ is a contactless breast-imaging tool cleared by the FDA specifically for adjunctive diagnostic screening for the detection of breast cancer.

5 Mar 2012

Nuvilex overcomes fundamental challenges faced in stem cell therapy

Nuvilex, Inc., an emerging biotechnology provider of cell and gene therapy solutions, released information today about the company's cell encapsulation technology and the breakthrough in stem cell research which overcomes specific fundamental challenges faced in stem cell therapy—host rejection and migration of implanted cells away from the target site.

5 Mar 2012

ETView completes Viva EB Endobronchial Blocker Technical File submission for review by MDC

ETView today announced that the company has successfully completed a Technical File submission for review by Medical Device Certification GmbH ("MDC"). The Technical File review initiates the Conformité Européenne, or "European Conformity" ("CE") registration process.

5 Mar 2012

HASCO Medical acquires Ride-Away Handicap Equipment

HASCO Medical, Inc., www.HascoMed.com a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, is pleased to announce that the Company has completed the acquisition of all of the outstanding capital stock of Ride-Away Handicap Equipment Corp., a closely-held New Hampshire corporation (Ride-Away).

5 Mar 2012

Bill Gates meets MTBVAC TB vaccine researchers in Spain

On 21 February Bill Gates met with Dr. Carlos Martin of the University of Zaragoza and members of his team in Madrid, Spain. The scientists are working on the development of MTBVAC, a new vaccine against tuberculosis (TB). Gates showed great interest in the scientific background of MTBVAC, the most advanced vaccine based on attenuation of Mycobacterium tuberculosis.

5 Mar 2012

Anthera continues Phase 2b PEARL-SC clinical study in SLE patients

Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases including cardiovascular and autoimmune disorders, today announced the continuation of the Phase 2b PEARL-SC clinical study following an interim analysis of all safety and efficacy data.

5 Mar 2012

Abbott, GenLab collaborate to develop new assay for PLEX-ID automated microbial identification system

Abbott announced today it will collaborate with Genetics Laboratory, Inc. on the development of a molecular diagnostic test that will be designed to rapidly detect microorganisms that cause orthopedic infections.

5 Mar 2012

Omega announces private placement of $400M senior notes offering

Omega Healthcare Investors, Inc. announced today its intention to offer $400 million aggregate principal amount of its senior notes due 2024 in a private placement, subject to market and other conditions.

5 Mar 2012

Concert commences dosing in CTP-499 Phase 2 clinical trial for diabetic nephropathy

Concert Pharmaceuticals, Inc. today announced the initiation of dosing in a Phase 2 clinical trial evaluating CTP-499, an investigational drug for the treatment of diabetic nephropathy, the leading cause of chronic kidney disease (CKD) in the US.

5 Mar 2012

FDA confirms FluCide pre-IND meeting date with NanoViricides

NanoViricides, Inc. announced today that March 29th, 2012 has been confirmed by the US FDA as the date for its initial meeting with the Company's scientists. This pre-IND meeting will focus on FluCide, designated as NV-INF-1, the Company's novel anti-influenza drug.

5 Mar 2012

Repligen seeks EMA marketing approval for SecreFlo for pancreatic imaging

Repligen Corporation announced today that it has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for SecreFlo to improve detection of pancreatic duct abnormalities in patients with pancreatitis.

5 Mar 2012

Varian to acquire InfiMed

Varian Medical Systems, Inc., today announced it has reached an agreement to acquire InfiMed, Inc., a privately-owned, leading supplier of workstations including hardware and software for processing diagnostic X-ray images. The acquisition, which is expected to close in early April subject to the satisfaction of certain closing conditions, will operate within Varian's X-Ray Products segment.

5 Mar 2012

Medical News

Inhalation of nitric oxide could help improve blood flow to ischemic brain

Health care a big budget issue for Minn., Va. lawmakers

Innovative telemedicine program connects neonatal specialists to treat tiniest, difficult cases

Interaction sends letter to CIA head protesting use of vaccination plot to find Bin Laden in Pakistan

Cell-based test to discover molecules to treat ER-positive breast cancer

USAID committed to early action on Sahel drought, drawing from lessons from Horn response

Thrombotech receives FDA IND approval for THR-18 Phase IIa clinical trial in stroke victims

IRIN examines pilot project to increase ORS coverage for treatment of child diarrhea

FDA clears UELS contactless breast cancer imaging tool

Nuvilex overcomes fundamental challenges faced in stem cell therapy

ETView completes Viva EB Endobronchial Blocker Technical File submission for review by MDC

HASCO Medical acquires Ride-Away Handicap Equipment

Bill Gates meets MTBVAC TB vaccine researchers in Spain

Anthera continues Phase 2b PEARL-SC clinical study in SLE patients

Abbott, GenLab collaborate to develop new assay for PLEX-ID automated microbial identification system

Omega announces private placement of $400M senior notes offering

Concert commences dosing in CTP-499 Phase 2 clinical trial for diabetic nephropathy

FDA confirms FluCide pre-IND meeting date with NanoViricides

Repligen seeks EMA marketing approval for SecreFlo for pancreatic imaging

Varian to acquire InfiMed

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News